The Computational and Translational Sciences team at Novasenta focuses on integrating cutting-edge computational biology with advanced translational research to identify novel druggable targets in cancer. By analyzing single-cell level data from high-quality human tumor samples, this team exploits the interplay between disease, immune response, and metabolism to accelerate the discovery and development of transformative cancer therapies.